OTC : NEGXF
$0 (0.0%)
OTC
Ronald C. Loucks
Medical - Healthcare Plans
Healthcare
NEGXF
20
CA
USD
0.04
1.16
1.16
1.12
0.65
$17.46M
1.77
3.68
8.98
0.05
$0.0137
$1.29M
10.88%
14.40%
24.30%
4.87%
18.09
0.10
0.10
4/5
0 Analysts
%
1.39
6/9
$5.06M
$40.97M
$32.13M
$2.88M
-$2.58M
-0.14
-0.64
1.16
24.30%
23.52%
6.12%
11.12%
$0.28
-79 days
| Name | Title |
|---|---|
| Richard Stevens | Vice President of Administration |
| Ronald C. Loucks | Founder, Chief Executive Officer, President & Director |
| Doreen Harvey | Lead Human Resources |
| Andrew Munroe | Vice President of Operations |
| Avik Debroy | Financial Controller |
| J. Padda | Director of Implementation |
| Kelly Ehler | Chief Financial Officer |
| Paul Anthony Bolger | Company Secretary |
No votes yet today — be the first to share your view!
About NexgenRx Inc. (OTC:NEGXF) Stock
NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug, dental, and various other extended healthcare claims for individuals covered by plans offered by its clients across Canada. Beyond core claims handling, NexgenRx offers Health Care Spending Accounts (HCSAs), providing individuals with dedicated funds for their health or dental expenses. Its service portfolio also encompasses individual and aggregate stop-loss insurance products, emergency medical and travel assistance insurance, and a suite of administrative support functions. These administrative services include the collection and disburseme ... nt of premiums for life and long-term disability (LTD) coverage, complemented by advanced reporting tools. To enhance convenience, the company facilitates online claims submission and direct deposit services, along with other specialized ancillary services.
2026-05-21 20:15:00
TORONTO, ON / ACCESS Newswire / May 21, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2026, with net income of $1,228,288 and EBITDA of $1,444,036, representing increases of $701,078 and $615,635, respectively, compared to the same period in 2025.
Frequently Asked Questions
What is the current NexgenRx Inc. (NEGXF) stock price?
NexgenRx Inc.(OTC:NEGXF) stock price is $0.325 in the last trading session. During the trading session, NEGXF stock reached the peak price of $0.325 while $0.2 was the lowest point it dropped to. The percentage change in NEGXF stock occurred in the recent session was 0.0% while the dollar amount for the price change in NEGXF stock was $0.
NEGXF's industry and sector of operation?
The OTC listed NEGXF is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector.
Who are the executives of NEGXF?
Richard Stevens
| Vice President of Administration
Ronald C. Loucks
| Founder, Chief Executive Officer, President & Director
Doreen Harvey
| Lead Human Resources
Andrew Munroe
| Vice President of Operations
Avik Debroy
| Financial Controller
How many employees does NEGXF have?
Number of NEGXF employees currently stands at 20. NEGXF operates from 185 The West Mall, Toronto, ON M9C 5L5, CA.
Link for NEGXF official website?
Official Website of NEGXF is: https://www.nexgenrx.com
How do I contact NEGXF?
NEGXF could be contacted at phone #+1 416 361 2244 and can also be accessed through its website. NEGXF operates from 185 The West Mall, Toronto, ON M9C 5L5, CA.
How many shares of NEGXF are traded daily?
The average number of NEGXF shares traded daily for last 3 months was 786.
What is the market cap of NEGXF currently?
The market value of NEGXF currently stands at $23.11M with its latest stock price at $0.325